0
Cardiothoracic Surgery |

Temporal Trends in Outcomes Following Sublobar and Lobar Resections for Small (< 2 cm) NSCLCs

Sai Yendamuri*, MD; Rohit Sharma, MD; Adrienne Groman, MS; Austin Miller, PhD; Todd Demmy, MD
Author and Funding Information

Roswell Park Cancer Institute, Buffalo, NY


Chest. 2012;142(4_MeetingAbstracts):47A. doi:10.1378/chest.1378016
Text Size: A A A
Published online

Abstract

SESSION TYPE: Thoracic Surgery II

PRESENTED ON: Tuesday, October 23, 2012 at 04:30 PM - 05:45 PM

PURPOSE: Since the randomized controlled study of sublobar resection vs. lobectomy for stage I NSCLCs by the Lung Cancer Study Group (LCSG), there have been improvements in staging. Also, the liberal use of computerized tomography may have altered the types of early lung cancer diagnosed. Studies published since then have drawn contradictory conclusions on the benefit of lobectomy over sublobar resections for early stage NSCLC. We examined the SEER database to assess the influence of these evolving factors on the relationship between the extent of resection and survival over the last two decades.

METHODS: Stage I NSCLCs < 2cm in size were examined over three time periods: 1988 - 1998 (Early), 1999 - 2004 (Intermediate) and 2005 - 2008 (Late). For each period, overall and disease-specific survival and their association with extent of resection was assessed by univariate and multivariate analyses. Sublobar resections in the ”Early” group could not be categorized into segmentectomies and wedge resections as these were not coded separately.

RESULTS: The proportion of NSCLCs < 2cm increased from 0.98% in 1988 to 2.2% in 2008. Multivariate analyses showed that sublobar resection was inferior to lobectomy in the “Early” period (HR=1.41; 95%CI=1.21-1.65). This effect decreased in the “Intermediate” period where segmentectomies but not wedge resections were equivalent to lobectomies (Wedge vs. Lobectomy HR = 1.19; 95%CI=1.01 - 1.41; Segmentectomy vs. Lobectomy HR =1.04; 95%CI=0.8-1.36). The difference disappeared in the “Late” period where both wedge resections and segmentectomies were equivalent to lobectomy(Wedge vs. Lobectomy HR = 1.09; 95%CI=0.79 - 1.5; Segmentectomy vs. Lobectomy HR =0.83; 95%CI=0.47-1.45). The trends for both overall survival and disease specific survival were identical.

CONCLUSIONS: The survival benefit of lobectomy over sublobar resection decreased over the last two decades with no discernible difference in the most contemporary cases.

CLINICAL IMPLICATIONS: These results support the hypothesis that better staging and earlier detection of less aggressive disease due to the expanding use of computerized tomography and PET/CT may make the results of the LCSG irrelevant to current clinical practice.

DISCLOSURE: The following authors have nothing to disclose: Sai Yendamuri, Rohit Sharma, Adrienne Groman, Austin Miller, Todd Demmy

No Product/Research Disclosure Information

Roswell Park Cancer Institute, Buffalo, NY

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543